MIAMI, September 15, 2021--(BUSINESS WIRE)--UroFill, a clinically proven non-surgical technique for girth enhancement of the penis, is now available in the US, Latin America and the European Union. A series of simple, painless, office-based outpatient treatments with the UroFill technique make almost any penile girth achievable.

The UroFill technique, an innovative, patented, non-surgical, first-in-class procedure developed by leading Miami-based urologist Paul Perito, MD, is being used by certified providers across the globe, including nine locations in the United States, Mexico, Colombia, and the Dominican Republic, with additional locations to be announced later this year.

All practitioners are Board-Certified Urologists and have been fully trained and certified by Dr. Perito and are able to perform the painless treatment in the privacy and comfort of the office. The procedures are performed under local anesthesia for patient comfort and a return to work immediately after the procedure, without restrictions. Most patients can resume sexual intercourse after 72 hours.

The UroFill technique is the only girth-enhancement procedure stemming from more than eight years of clinical review and testing. The procedure safely enhances penile girth without the need for surgery. It utilizes an FDA-approved dermal filler similar to tissue enhancement fillers commonly used on the lips, face, neck or other sensitive areas of the body. Dr. Perito’s patented UroFill method is unique in its delivery of the material and its adaptation to the penis. UroFill fully maximizes long-term cosmetic outcomes.

Documented patient satisfaction is consistently high, with more than 90% of patients reporting filler retention nearly two years after the initial procedure.

UroFill is a registered trademark of UroFill, LLC.

UroFill™ is an innovative new method to achieve penile girth enhancement that is a non-surgical procedure using a proprietary dermal filler. The outcome is functionally and cosmetically appealing with durable results. Created by one of the world’s leading urologists, Miami-based Paul Perito, MD, of Perito Urology, the patented technique is safe, effective and minimally invasive. Learn more by visiting www.urofill.com or calling 1-833-UROFILL.

For more information, to arrange interviews with UroFill certified doctors or patients, or to receive images, contact Paul Williams at 310/569-0023 or via paul@medialinecommunications.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210915005853/en/

Paul Williams, 310/569-0023 paul@medialinecommunications.com

As we move toward the end of Q2, it’s time to start thinking about earnings. Looking back at the quarter, analysts are predicting earnings growth of 8%, which may rise to 11% heading into next year. It’s a rosy picture, but it’s also not a sure thing. GDP contracted in Q1, by nearly 1.5%, and some estimates are showing 0% growth in Q2. Such results would meet the technical definition of a recession – and recession is hardly the usual environment to find robust earnings growth. Looking at current

Nuclear submarine supplier to be sold to US buyer after diplomatic row Russian default expected within days Retail sales volumes down 0.5pc in May FTSE 100 rises strongly Ambrose Evans-Pritchard: The pro-Brussels establishment is painting Brexit as an economic disaster to reverse it Sign up here for our daily business briefing newsletter

When you need another stream of income for retirement, you might consider an annuity. You purchase the annuity from an insurance company and receive payments back at a later date. Before buying an annuity, it's important to consider how much … Continue reading → The post How Much Does a $300,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

Shares of the specialty pharmaceutical company Bausch Health Companies (NYSE: BHC) are surging today in response to the news that Joseph Papa has resigned from the board of directors effective immediately. Over the past six years, Papa has been instrumental in lowering the company's sky-high debt and keeping it out of bankruptcy court. Bausch said in a statement Thursday evening that billionaire hedge fund manager John Paulson will fill the vacant board position.

In this article, we will take a look at 10 value stocks to buy according to billionaire David Tepper. If you want to skip our discussion on Tepper’s history and his hedge fund’s performance, go directly to 5 Value Stocks to Buy According to Billionaire David Tepper. With a net worth of $16.7 billion, David […]

High-yield dividend stocks are a major component of my stock portfolio. Here are three income stocks that have room for solid gains in the next year and even better gains over the long run. The blue-chip business development company (BDC) Main Street Capital (NYSE: MAIN) has held up better than the S&P 500 index, which is down 21% so far this year.

“Time is running out for cash-burning companies kept afloat with easy access to capital,” New Constructs CEO David Trainer said in a Thursday research note.

At an all-hands meeting at Twitter (TWTR) on June 16, its prospective owner, Elon Musk, reportedly called free speech "essential."

Tesla plant near Shanghai is going to shut down temporarily, according to reports. On Wednesday, Reuters reported that Tesla (ticker: TSLA) will shut down production in China for a couple of weeks at the start of July to upgrade equipment. Tesla didn’t return a request for comment.

The days of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) stock trading above $2,000 are numbered. Investors often eagerly anticipate stock splits because they think shares could take off after the split. Let's first address the significance (or lack thereof) of stock splits.

In this article, we will look at 10 stocks to profit from inflation. If you want to explore similar stocks, you can also read 5 Stocks to Profit from Inflation. Billionaire investor and hedge fund manager of the world’s largest hedge fund, Bridgewater Associates, Ray Dalio shared his views on the current economic situation that […]

Energy prices are high. But bargain-hunter Buffett continues to bet on big oil.

The merger between the special-purpose acquisition company Gores Guggenheim and the electric-vehicle company coming from Volvo is done.

At current levels, investors need a 7% to 8% return just to preserve their wealth.

SEAL Team is expanding its ranks, adding Raffi Barsoumian (Legends of Tomorrow) as a new series regular for Season 6 of the Paramount+ drama. The actor will play Omar, “a Senior Chief with 15 years of experience as a SEAL,” our sister site Deadline reports. “The son of Syrian immigrants, Omar has a deep understanding […]

Shares of CalAmp (NASDAQ: CAMP) were tumbling today after the company reported first-quarter results that missed Wall Street's top- and bottom-line expectations. CalAmp reported a non-GAAP (adjusted) loss per share of $0.10 in the quarter, which was much worse than analysts' consensus estimate of a loss of $0.03. The company's revenue of $64.7 million -- a decrease of nearly 19% from the year-ago quarter -- was also below Wall Street's average estimate of $69.4 million.

Russia’s fiddling with gas flows to Europe could create an economic spillover effect, warns Germany’s top economy minister.

Downturns can bring a lot of pain, but they can also bring on plenty of opportunities, as lower stock prices start making costs of entry more attractive. Before taking advantage of these opportunities, however, investors need to find a recognizable signal that will set them apart. One popular signal to follow is the insider buying, the trades made by high-ranking company officers whose positions give them the ‘inside’ track on their company’s likely prospects – and therefore, of the stock’s pros

Weitz Investment Management, an investment management firm, published its “Partners III Opportunity Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. The Partners III Opportunity Fund’s Institutional Class returned -5.09% in the first quarter of 2022 compared with -4.60% for the S&P 500 and -5.28% for the Russell 3000. […]

The drop is exciting some Berkshire investors because the stock now trades for 1.3 times Barron's estimate of its June 30 book value, compared with more than 1.5 times at its March high.